Sapropterin dihydrochloride

For research use only. Not for therapeutic Use.

  • CAT Number: I004598
  • CAS Number: 69056-38-8
  • Molecular Formula: C9H15N5O3 • 2HCl
  • Molecular Weight: 314.2
  • Purity: ≥95%
Inquiry Now

Sapropterin dihydrochloride (CAT: I004598) is a synthetic form of tetrahydrobiopterin (BH4), a cofactor involved in the synthesis of neurotransmitters such as dopamine, serotonin, and norepinephrine. It is primarily used as a medication to treat phenylketonuria (PKU), a genetic disorder that impairs the body’s ability to process the amino acid phenylalanine. Sapropterin dihydrochloride helps increase the levels of functional BH4 in the body, thereby improving the metabolism of phenylalanine and reducing its buildup in individuals with PKU. By managing phenylalanine levels, sapropterin dihydrochloride can help prevent or minimize the neurological and cognitive complications associated with PKU.


Catalog Number I004598
CAS Number 69056-38-8
Synonyms

BH4

Molecular Formula C9H15N5O3 • 2HCl
Purity ≥95%
Target Disease Research Fields
Solubility H2O: ≥ 34 mg/mL
Storage -20°C
Overview of Clinical Research

<p>
<span style=”color:#000000;”><span style=”font-family:arial,helvetica,sans-serif;”><span style=”font-size:12px;”>Sapropterin dihydrochloride is a n<span style=”font-variant-ligatures: normal; orphans: 2; widows: 2;”>itric oxide synthase stimulant and a phenylalanine hydroxylase stimulant.&nbsp;</span><span style=”font-variant-ligatures: normal; orphans: 2; widows: 2;”>Biomarin Pharmaceuticals completed a phase III extension trial for Phenylketonuria (PO) in Germany, Ireland, Italy and United Kingdom (EudraCT2004-004513-41) in 2019.</span></span></span></span></p>

IUPAC Name (6R)-2-amino-6-[(1R,2S)-1,2-dihydroxypropyl]-5,6,7,8-tetrahydro-3H-pteridin-4-one;dihydrochloride
InChI InChI=1S/C9H15N5O3.2ClH/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7;;/h3-4,6,12,15-16H,2H2,1H3,(H4,10,11,13,14,17);2*1H/t3-,4+,6-;;/m0../s1
InChIKey RKSUYBCOVNCALL-NTVURLEBSA-N
SMILES CC(C(C1CNC2=C(N1)C(=O)NC(=N2)N)O)O.Cl.Cl
Reference

<p style=”/line-height:25px/”>
<br />
[1]. Winn SR et al. High dose sapropterin dihydrochloride therapy improves monoamine neurotransmitter turnover in murine phenylketonuria (PKU). Mol Genet Metab. 2016 Jan;117(1):5-11.<br />
[2]. Somaraju UR et al. Sapropterin dihydrochloride for phenylketonuria. Cochrane Database Syst Rev. 2015 Mar 27<br />
[3]. Jurecki ER et al. Sapropterin Dihydrochloride Mixed With Common Foods and Beverages. Top Clin Nutr. 2014 Oct;29(4):325-331.<br />
[4]. Grange DK et al. Sapropterin dihydrochloride use in pregnant women with phenylketonuria: an interim report of the PKU MOMS sub-registry. Mol Genet Metab. 2014 May;112(1):9-16</p>

Request a Quote